/R E P E A T -- Media advisory - Government of Canada to make an announcement on investing in medical isotopes sector to ensure that Canadians have access to the best health care possible/
KINCARDINE, ON, June 26, 2023 /CNW/ - Pam Damoff, Parliamentary Secretary to the Minister of Public Safety, will be making an announcement on behalf of the Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry.
Date:
Tuesday, June 27, 2023
Time:
1 pm (ET)
Location:
Bruce Power Visitors' Centre 3394 Bruce County Road 20 Kincardine, Ontario
Note to media
Members of the media are asked to contact ISED Media Relations at [email protected] to confirm their attendance or obtain the dial-in information to participate via teleconference.
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...
The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. ("agilon" or the "Company"). This action, captioned Hope v. agilon health, inc., et...
bioLytical Laboratories Inc. announced today the immediate availability of its INSTI® HCV Antibody Test in the Australian market. The INSTI Hepatitis C (HCV) Antibody Test is now included in the Australian Register of Therapeutic Goods (ARTG...
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego,...
